PET with 2-[F-18]-fluoro-2-deoxy-D-glucose (FDG) in patients with cancer of unknown primary (CUP): influence on patients' diagnostic and therapeutic management.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples